• Evidence-Based Strategic Insight
  • Established Investigator Relationships
  • Medical Oncology Expertise
  • Site-Specific Accrual Support
  • Measurable & Proven Results


Strategic Consulting: DAVA’s evidence-based strategic insights provide tools to make tactical decisions during the development of a biological substance. We offer numerous products and services customized to fit biopharmaceutical drug development needs.  

Trial Acceleration: DAVA’s dedicated medical oncology team make timely clinical trial completion a reality. Whether enrollment planning and referral outreach, site identification, or protocol feasibility, DAVA has the tools a trial needs to succeed. 

Upcoming Events

National Summits

Hematologic Malignancies

March 30-April 2
Whistler, BC, Canada

Genitourinary Malignancies
September 22-23
Coral Gables, FL

Regional Summits

B-Cell and Plasma Cell Malignancies CLL, Lymphoma, Multiple Myeloma
Sept. 30 - Chicago, IL
Oct. 7 - Seattle, WA

Acute Leukemias, Myeloproliferative Neoplasms, and Allogeneic Transplant
October 14 - New York, NY
October 21 - Pasadena, CA

Expert Forums

Non-Hodgkin and Hodgkin Lymphoma
July 14-15
Dallas, TX

Harnessing the Immune System in Cancer
July 28-29
Dallas, TX

Chronic Lymphocytic Leukemia
August 4-5
Dallas, TX

Multiple Myeloma
August 11-12
Dallas, TX

Thoracic Malignancies and Head and Neck Cancer
November 3-4
Dallas, TX